American Oriental Bioengineering Reports Third Quarter 2008 Financi...(ties 680544 ...)

Total Current

Liabilities 34,573,084 26,460,778

LONG-TERM LIABILITIES

Long-term bank loans, net of current

portion 818,058 1,263,483

Long-term notes payable 297,390 286,365

Deferred tax liabilities 16,390,430 12,621,180

Convertible Note 115,000,000 --

Total Long-Term

Liabilities 132,505,878 14,171,028

TOTAL LIABILITIES 167,078,962 40,631,806

COMMITMENTS

SHAREHOLDERS' EQUITY

Preferred stock, $0.001 par value;

2,000,000 shares authorized;

1,000,000 shares issued and

outstanding at September 30, 2008

and December 31, 2007, respectively 1,000 1,000

Common stock, $0.001 par value;

150,000,000 shares authorized;

78,249,264 and 77,991,935 shares

issued and outstanding at September

30, 2008 and December 31, 2007,

respectively 78,249 77,992

Common stock to be issued 279,332 1,611,333

Prepaid forward repurchase contract (29,998,616) --

Additional paid-in capital 195,500,513 193,007,987

Retained earnings (the restricted

portion of retained earnings is

$15,910,685 at September 30, 2008

and December 31, 2007, respectively) 141,882,532 102,117,792

Accumulated other comprehensive

income 29,085,454 16,266,986

Total Shareholders'

Equity 336,828,464 313,083,090

TOTAL
'/>"/>